Related Experiment Video
Updated: Mar 10, 2026
Murine Myocardial Infarction Model using Permanent Ligation of Left Anterior Descending Coronary Artery
Published on: August 16, 2019
miR-539 as a key negative regulator of the MEK pathway in myocardial infarction
1Department of Cardiovascular Surgery, The General Hospital of Shenyang Military Region, No. 83Wenhua Road, 110016, Shenhe District, Shenyang, Liaoning, China.
Insights
MicroRNA-539 (miR-539) overexpression increases myocardial infarction severity by inhibiting MEK protein. This suggests miR-539 is a potential therapeutic target for heart attack treatment.
Area of Science:
- Cardiovascular Research
- Molecular Biology
- Biomarker Discovery
Background:
- Myocardial infarction (MI) is a leading cause of mortality with increasing prevalence.
- Accurate and timely diagnosis of MI is critical for patient outcomes but remains challenging.
- Novel biomarkers and risk prediction tools are needed for effective MI management.
Purpose of the Study:
- To investigate the role of microRNA-539 (miR-539) in myocardial infarction.
- To explore the relationship between miR-539 and MEK protein expression in a rat MI model.
Main Methods:
- Utilized a rat model to study myocardial infarction.
- Quantified the expression levels of miR-539 and MEK protein.
- Investigated the inhibitory mechanism of miR-539 on MEK expression.
Main Results:
- Observed increased miR-539 expression and decreased MEK protein expression in the MI model.
- Demonstrated that miR-539 directly targets the 3'UTR of MEK, inhibiting its expression.
- Found that miR-539 overexpression suppressed H9C2 cell proliferation and induced apoptosis and autophagy.
Conclusions:
- Overexpression of miR-539 is implicated in the severity of myocardial infarction.
- miR-539 shows potential as a novel therapeutic target for treating myocardial infarction.
Background:
Myocardial infarction is one of the most common causes of death, and the number of individuals at risk is increasing. A rapid and accurate differential diagnosis of myocardial infarction is crucial for timely interventions and for improvement of the prognosis. However, it is difficult to achieve using current methods. To better manage this condition, improved tools for risk prediction, including more accurate biomarkers, are needed.
Methods:
We studied the expression of microRNA-539 (miR-539) and of MEK protein using a rat model of myocardial infarction.
Results:
The results of our experiments demonstrated an increase in the expression of miR-539 and a decrease in the expression of MEK. Furthermore, we observed that miR-539 inhibited the expression of MEK through targeting of the 3'UTR of MEK; this led not only to suppressed proliferation but also to apoptosis and autophagy of H9C2 cells.
Conclusion:
Overexpression of miR-539 plays a role in the degree of myocardial infarction. On the basis of our results, we conclude that miR-539 may be a potential therapeutic target for myocardial infarction.
